Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI ...

Shares of Cipla skyrocketed 10 percent on October 31 after the US Food and Drug Administration classified the drugmaker's Goa manufacturing facility as 'Voluntary Action Indicated' (VAI), thereby ...

Stock Market Today: Cipla share price gained 10% in the morning trade on Thursday, October 31 after the company announced that its Goa facility has been classified as Voluntary Action Indicated (VAI).

Revenue: INR 7,051 crores, growth of 9% year-on-year. EBITDA Margin: 26.7%, highest ever quarterly margin for Cipla. Gross Margin: 67.6%, up 159 basis points from last year. Profit After Tax ...